Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand

Chayanid Kunanukulwatana, Fuanglada Tongprasert, Suchaya Luewan, Theera Tongsong Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandCorrespondence: Fuanglada Tongprasert, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai Un...

Full description

Saved in:
Bibliographic Details
Main Authors: Kunanukulwatana C, Tongprasert F, Luewan S, Tongsong T
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:International Journal of Women's Health
Subjects:
Online Access:https://www.dovepress.com/effectiveness-of-fetal-medicine-foundations-non-biochemical-risk-calcu-peer-reviewed-fulltext-article-IJWH
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850157391032614912
author Kunanukulwatana C
Tongprasert F
Luewan S
Tongsong T
author_facet Kunanukulwatana C
Tongprasert F
Luewan S
Tongsong T
author_sort Kunanukulwatana C
collection DOAJ
description Chayanid Kunanukulwatana, Fuanglada Tongprasert, Suchaya Luewan, Theera Tongsong Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandCorrespondence: Fuanglada Tongprasert, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand, Tel +66-53-935552, Email fuanglada.t@cmu.ac.thPurpose: To evaluate the efficacy of first-trimester non-biochemical screening using the Fetal Medicine Foundation (FMF) algorithm in predicting fetal common trisomies (trisomy 21, 18, and 13) in clinical practice.Patients and Methods: Between 2011 and 2023, the non-biochemical screening was routinely performed at 11+0-13+6 weeks’ gestation in 9591 singleton pregnancies at Maharaj Nakorn Chiang Mai Hospital, Thailand. The individual risks for common fetal trisomies were calculated by combining maternal age, history of common trisomies in a previous pregnancy, nuchal translucency thickness, and fetal heart rate using the official FMF algorithm. Women with risk of ≥ 1:250 were classified as high risk. The fetal karyotyping results and pregnancy outcomes were reviewed and analyzed.Results: A total of 8491 complete data sets of singleton pregnancies were analyzed. The incidence of common trisomies was 0.5% (46 cases), including 0.3% (28 cases) of trisomy 21, 0.1% (9 cases) of trisomy 18 and 0.1% (9 cases) of trisomy 13. With a cut-off risk of 1:250, FMF algorithm performance for trisomy 21 screening had a sensitivity of 60.7%, specificity of 97.6%, PPV of 7.7%, NPV of 99.9%, and a false positive rate of 2.4%. The performance for detecting all common trisomies demonstrated a sensitivity of 52.2%, specificity of 97.2%, PPV of 9.2%, NPV of 99.7%, and a false positive rate 2.8%.Conclusion: The first trimester non-biochemical FMF algorithm is sufficiently effective in predicting common trisomies, particularly trisomy 21. This simple approach can be easily implemented in clinical practice, including healthcare facilities that lack access to maternal blood testing services.Keywords: trisomy, down syndrome, prenatal screening, first trimester screening, nuchal translucency
format Article
id doaj-art-0ea70e589e5c40e3a6092addb8b03b72
institution OA Journals
issn 1179-1411
language English
publishDate 2025-06-01
publisher Dove Medical Press
record_format Article
series International Journal of Women's Health
spelling doaj-art-0ea70e589e5c40e3a6092addb8b03b722025-08-20T02:24:09ZengDove Medical PressInternational Journal of Women's Health1179-14112025-06-01Volume 17Issue 116931699103596Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern ThailandKunanukulwatana C0Tongprasert F1Luewan S2Tongsong T3Department of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyObstetrics and GynecologyObstetrics and GynecologyChayanid Kunanukulwatana, Fuanglada Tongprasert, Suchaya Luewan, Theera Tongsong Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandCorrespondence: Fuanglada Tongprasert, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand, Tel +66-53-935552, Email fuanglada.t@cmu.ac.thPurpose: To evaluate the efficacy of first-trimester non-biochemical screening using the Fetal Medicine Foundation (FMF) algorithm in predicting fetal common trisomies (trisomy 21, 18, and 13) in clinical practice.Patients and Methods: Between 2011 and 2023, the non-biochemical screening was routinely performed at 11+0-13+6 weeks’ gestation in 9591 singleton pregnancies at Maharaj Nakorn Chiang Mai Hospital, Thailand. The individual risks for common fetal trisomies were calculated by combining maternal age, history of common trisomies in a previous pregnancy, nuchal translucency thickness, and fetal heart rate using the official FMF algorithm. Women with risk of ≥ 1:250 were classified as high risk. The fetal karyotyping results and pregnancy outcomes were reviewed and analyzed.Results: A total of 8491 complete data sets of singleton pregnancies were analyzed. The incidence of common trisomies was 0.5% (46 cases), including 0.3% (28 cases) of trisomy 21, 0.1% (9 cases) of trisomy 18 and 0.1% (9 cases) of trisomy 13. With a cut-off risk of 1:250, FMF algorithm performance for trisomy 21 screening had a sensitivity of 60.7%, specificity of 97.6%, PPV of 7.7%, NPV of 99.9%, and a false positive rate of 2.4%. The performance for detecting all common trisomies demonstrated a sensitivity of 52.2%, specificity of 97.2%, PPV of 9.2%, NPV of 99.7%, and a false positive rate 2.8%.Conclusion: The first trimester non-biochemical FMF algorithm is sufficiently effective in predicting common trisomies, particularly trisomy 21. This simple approach can be easily implemented in clinical practice, including healthcare facilities that lack access to maternal blood testing services.Keywords: trisomy, down syndrome, prenatal screening, first trimester screening, nuchal translucencyhttps://www.dovepress.com/effectiveness-of-fetal-medicine-foundations-non-biochemical-risk-calcu-peer-reviewed-fulltext-article-IJWHtrisomyDown syndromeprenatal screeningfirst trimester screeningnuchal translucency
spellingShingle Kunanukulwatana C
Tongprasert F
Luewan S
Tongsong T
Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
International Journal of Women's Health
trisomy
Down syndrome
prenatal screening
first trimester screening
nuchal translucency
title Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
title_full Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
title_fullStr Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
title_full_unstemmed Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
title_short Effectiveness of Fetal Medicine Foundation’s Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11–13 weeks of Gestation: 12 Years’ Experience in Northern Thailand
title_sort effectiveness of fetal medicine foundation amp rsquo s non biochemical risk calculation algorithm in detection of common trisomies screening at 11 amp ndash 13 amp nbsp weeks of gestation 12 years amp rsquo experience in northern thailand
topic trisomy
Down syndrome
prenatal screening
first trimester screening
nuchal translucency
url https://www.dovepress.com/effectiveness-of-fetal-medicine-foundations-non-biochemical-risk-calcu-peer-reviewed-fulltext-article-IJWH
work_keys_str_mv AT kunanukulwatanac effectivenessoffetalmedicinefoundationamprsquosnonbiochemicalriskcalculationalgorithmindetectionofcommontrisomiesscreeningat11ampndash13ampnbspweeksofgestation12yearsamprsquoexperienceinnorthernthailand
AT tongprasertf effectivenessoffetalmedicinefoundationamprsquosnonbiochemicalriskcalculationalgorithmindetectionofcommontrisomiesscreeningat11ampndash13ampnbspweeksofgestation12yearsamprsquoexperienceinnorthernthailand
AT luewans effectivenessoffetalmedicinefoundationamprsquosnonbiochemicalriskcalculationalgorithmindetectionofcommontrisomiesscreeningat11ampndash13ampnbspweeksofgestation12yearsamprsquoexperienceinnorthernthailand
AT tongsongt effectivenessoffetalmedicinefoundationamprsquosnonbiochemicalriskcalculationalgorithmindetectionofcommontrisomiesscreeningat11ampndash13ampnbspweeksofgestation12yearsamprsquoexperienceinnorthernthailand